In this paper, we report the results of the studies on the impact of this molecule on the proliferation of ovarian cancer cell line IGROV1, by confirming the effect of compound 3 on cell growth; investigating the expression of key cell cycle regulators, ERβ colocalization, and changes in the histones post-translational modifications pattern; and performing molecular docking. Here, ESR2 is linked to ovarian cancer.